Latin America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)

Latin America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)

ID: 6405 | Pages: 145 | February 2018 | Region: Latin America


The Latin America Rubella Vaccine (Human Diploid Cell) market is anticipated to grow at XX % CAGR from 2017 to 2022 and it is estimated that the Latin America market was valued at USD XX billion in 2017 and is expected to reach USD XX billion by 2022.

Rubella is an acute, viral, and contagious infection, which has a mild effect on children and is caused by the transmission of airborne droplets of infected people through sneezing or coughing. However, pregnant women suffering from rubella have to face severe consequences, as the viral infection results in death or congenital defects known as congenital rubella syndrome (CRS). Rubella vaccine has gained traction over the years as the disease is preventable only through vaccination and no other specific treatments exist for it.

The major factors that fuel the growth of the market are an increase in the incidence of rubella infection Approximately 100,000 infants are affected by rubella annually, thus increasing the government focus on rubella vaccination, which further propels the market growth. However, inherent disadvantages of using human diploid cell technology for constructing rubella vaccines such as high selectivity and insufficient yield, restrain the growth of the market. Conversely, ongoing R&D activities for the advancement of rubella vaccines are expected to offer lucrative opportunities for the growth of the market.

The Latin America Rubella Vaccine market is segmented on the basis of End User. On the basis of End User, the market is segmented into Pediatric Rubella Vaccine, Adult Rubella Vaccine, and Traveler Rubella Vaccine.

On the basis of geography, the Rubella Vaccine market is segmented into Argentina, Brazil and Mexico.

The market is dominated by companies like Merck & Co., Inc., GlaxoSmithKline Plc, Chiron Corporation (Novartis), Sanofi-Aventis, Serum Institute of India, Astellas Pharma Inc., AstraZeneca Plc. (Medimmune, LLC.), CSL Limited, Pfizer Inc., and Berna Biotech (Crucell).

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 End User                                      

                                5.1.1 Introduction                           

                                5.1.2 Pediatric Rubella Vaccine                  

                                5.1.3 Adult Rubella Vaccine                         

                                5.1.4 Traveler Rubella Vaccine                   

                                5.1.5  Y-o-Y Growth Analysis, By End User                            

                                5.1.6  Market Attractiveness Analysis, By End User                          

                                5.1.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By End User        

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By End User        

                6.2 Brazil                                             

                6.3 Mexico                                         

                6.4 Rest of Latin America                                             

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Merck & Co. Inc.                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 GlaxoSmithKline Plc                                

                8.3 Chiron Corporation                                 

                8.4 Sanofi-Aventis                                          

                8.5 Serum Institute of India                                        

                8.6 Astellas Pharma Inc.                                               

                8.7 AstraZeneca Plc.                                       

                8.8 CSL Limited                                 

                8.9 Pfizer Inc.                                    

                8.10 Berna Biotech                                         

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by End user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

TitlePriceAdd To Cart

Latin America Rubella Vaccine  Market By End User, From 2017-2022 ( USD Million )

Latin America Pediatric Rubella Vaccine Market By Region, From 2017-2022 ( USD Million )

Latin America Adult Rubella Vaccine  Market By Region, From 2017-2022 ( USD Million )

Latin America Traveler Rubella Vaccine Market By Region, From 2017-2022 ( USD Million )

Brazil Rubella Vaccine  Market By End User, From 2017-2022 ( USD Million )

Argentina Rubella Vaccine  Market By End User, From 2017-2022 ( USD Million )

Mexico Rubella Vaccine  Market By End User, From 2017-2022 ( USD Million )

Rest of Latin America Rubella Vaccine  Market By End User, From 2017-2022 ( USD Million )

Middle East And Africa Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (...
Latin America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Asia Pacific Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 20...
Europe Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
North America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
Middle-East And Africa Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growt...
Latin America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Asia-Pacific Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends,...
Europe Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And F...
North America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.